Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis.
Diagnosis of rheumatoid arthritis (RA) is mainly based on clinical criteria of symmetric polyarthritis of the hands and feet, with morning stiffness lasting usually more than 1 h. Autoantibodies typical for RA, i.e., rheumatoid factors and anti-cyclic citrullinated peptide, and measurements of inflammation add more specific information, especially for early diagnosis, where clinical presentation may be oligosymptomatic involving only a few joints. These laboratory parameters are also relevant for prognosis of disease persistence, functional impairment and radiological progression.
Rheumaklinik Aachen, Aachen, Germany. mierau.rmn@t-online.de
Rudolf
R
Mierau
Ekkehard
E
Genth
D001172:Arthritis, Rheumatoid / Q000175:diagnosis*; D001323:Autoantibodies / Q000097:blood*; D001681:Biological Assay; D015415:Biomarkers / Q000097:blood; D003937:Diagnosis, Differential; D006801:Humans; D010456:Peptides, Cyclic / Q000097:blood / Q000276:immunology; D011379:Prognosis; D012217:Rheumatoid Factor / Q000097:blood / Q000276:immunology; D012985:Software Design
D001323:Autoantibodies; D015415:Biomarkers; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide; D012217:Rheumatoid Factor